{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:06:27Z","timestamp":1770141987327,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.lana.2023.100427","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T18:52:31Z","timestamp":1675795951000},"page":"100427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lifetime quality-adjusted life years lost due to genital herpes acquired in the United States in 2018: a mathematical modeling study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-7521","authenticated-orcid":false,"given":"Shiying","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Yaesoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyueun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Eppink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrell W.","family":"Chesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Gift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-290X","authenticated-orcid":false,"given":"Andr\u00e9s A.","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-5670","authenticated-orcid":false,"given":"Minttu M.","family":"R\u00f6nn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lana.2023.100427_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lana.2023.100427_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lana.2023.100427_bib4","series-title":"Aseptic meningitis in adults","author":"Tunkel","year":"2022"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib5","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","article-title":"First estimates of the global and regional incidence of neonatal herpes infection","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.lana.2023.100427_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/OLQ.0000000000001375","article-title":"Estimates of the prevalence and incidence of genital herpes, United States, 2018","volume":"48","author":"Spicknall","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.lana.2023.100427_bib7","doi-asserted-by":"crossref","first-page":"ofab218","DOI":"10.1093\/ofid\/ofab218","article-title":"Analytic characterization of the herpes simplex virus type 2 epidemic in the United States, 1950-2050","volume":"8","author":"Ayoub","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12916-019-1285-x","article-title":"Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions","volume":"17","author":"Ayoub","year":"2019","journal-title":"BMC Med"},{"issue":"14","key":"10.1016\/j.lana.2023.100427_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJMra0807633","article-title":"Maternal and neonatal herpes simplex virus infections","volume":"361","author":"Corey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.lana.2023.100427_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/OLQ.0000000000001371","article-title":"Lifetime medical costs of genital herpes in the United States: estimates from insurance claims","volume":"48","author":"Eppink","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"4 Pt 1","key":"10.1016\/j.lana.2023.100427_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0029-7844(96)00261-X","article-title":"Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis","volume":"88","author":"Randolph","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AOG.0000000000004181","article-title":"Herpes simplex virus serotyping in pregnant women with a history of genital herpes and an outbreak in the third trimester of pregnancy: a cost-effectiveness analysis","volume":"137","author":"Chatroux","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.lana.2023.100427_bib13","series-title":"Neonatal herpes simplex virus infection: management and prevention","author":"Demmler-Harrison","year":"2022"},{"issue":"50","key":"10.1016\/j.lana.2023.100427_bib14","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1016\/j.vaccine.2017.03.074","article-title":"Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling","volume":"37","author":"Gottlieb","year":"2019","journal-title":"Vaccine"},{"issue":"10053","key":"10.1016\/j.lana.2023.100427_bib15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2023.100427_bib16","first-page":"27","article-title":"Psychological and psychosexual implications of herpes simplex virus infections","volume":"100","author":"Mindel","year":"1996","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.lana.2023.100427_bib17","series-title":"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection","author":"Albrecht","year":"2022"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/sti.2004.011619","article-title":"Health related quality of life in genital herpes: a pilot comparison of measures","volume":"81","author":"Fisman","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"12","key":"10.1016\/j.lana.2023.100427_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1473-3099(17)30405-X","article-title":"Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis","volume":"17","author":"Looker","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00007435-200302000-00015","article-title":"Natural history of genital herpes simplex virus type 1 infection","volume":"30","author":"Engelberg","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.lana.2023.100427_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: clinical manifestations, course, and complications","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lana.2023.100427_bib22","series-title":"Sexually transmitted diseases","first-page":"399","article-title":"Genital herpes","author":"Corey","year":"2008"},{"issue":"8405","key":"10.1016\/j.lana.2023.100427_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(84)92623-0","article-title":"Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients","volume":"2","author":"Sk\u00f6ldenberg","year":"1984","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.lana.2023.100427_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007435-200210000-00008","article-title":"Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States","volume":"29","author":"Fisman","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2023.100427_bib25","series-title":"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection","author":"Johnston","year":"2022"},{"key":"10.1016\/j.lana.2023.100427_bib26","series-title":"Screening for genital herpes simplex: brief update for the US Preventive Services Task Force","author":"Glass","year":"2005"},{"key":"10.1016\/j.lana.2023.100427_bib51","series-title":"Treatment of genital herpes simplex virus infection","author":"Albrecht","year":"2022"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib23","first-page":"40","article-title":"A\u00a0prospective study of the psychological impact on patients with a first episode of genital herpes","volume":"70","author":"Carney","year":"1994","journal-title":"Genitourin Med"},{"key":"10.1016\/j.lana.2023.100427_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/369172","article-title":"The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention","volume":"2013","author":"Gantt","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.lana.2023.100427_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-121-11-199412010-00004","article-title":"Recurrence rates in genital herpes after symptomatic first-episode infection","volume":"121","author":"Benedetti","year":"1994","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.lana.2023.100427_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM200003233421203","article-title":"Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons","volume":"342","author":"Wald","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl_8","key":"10.1016\/j.lana.2023.100427_bib31","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Workowski","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-131-1-199907060-00004","article-title":"Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time","volume":"131","author":"Benedetti","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lana.2023.100427_bib33","article-title":"The Truven Health MarketScan databases for life sciences researchers","author":"Hansen","year":"2017","journal-title":"Merative"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/514600","article-title":"Herpes simplex viruses","volume":"26","author":"Whitley","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lana.2023.100427_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archneur.65.5.596","article-title":"Neurological complications of herpes simplex virus type 2 infection","volume":"65","author":"Berger","year":"2008","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jval.2015.11.003","article-title":"Sources and characteristics of utility weights for economic evaluation of pediatric vaccines: a systematic review","volume":"19","author":"Herdman","year":"2016","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/INF.0b013e3181f55a5c","article-title":"A\u00a0report of three cases and review of intrauterine herpes simplex virus infection","volume":"30","author":"Marquez","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lana.2023.100427_bib38","series-title":"Neonatal herpes simplex virus infection: clinical features and diagnosis","author":"Demmler-Harrison","year":"2022"},{"key":"10.1016\/j.lana.2023.100427_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4419-7185-2_15","article-title":"Neonatal herpes simplex virus infections: where are we now?","volume":"697","author":"Thompson","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.17.1.1-13.2004","article-title":"Neonatal herpes simplex infection","volume":"17","author":"Kimberlin","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.lana.2023.100427_bib41","first-page":"1551","article-title":"Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis","volume":"3","author":"Mennemeyer","year":"1997","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1542\/peds.108.2.230","article-title":"Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib43","article-title":"Depression and anxiety following early pregnancy loss: recommendations for primary care providers","volume":"17","author":"Nynas","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.lana.2023.100427_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-3-18","article-title":"The course of mental health after miscarriage and induced abortion: a longitudinal, five-year follow-up study","volume":"3","author":"Broen","year":"2005","journal-title":"BMC Med"},{"issue":"3 Pt 2","key":"10.1016\/j.lana.2023.100427_bib45","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ajog.2005.05.042","article-title":"Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis","volume":"193","author":"Little","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.lana.2023.100427_bib46","first-page":"1","article-title":"United States life tables, 2018","volume":"69","author":"Arias","year":"2020","journal-title":"Natl Vital Stat Rep"},{"issue":"13","key":"10.1016\/j.lana.2023.100427_bib47","first-page":"1","article-title":"Births: final data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"10.1016\/j.lana.2023.100427_bib48","first-page":"511","article-title":"Procedure-related miscarriages and Down syndrome\u2013affected births: implications for prenatal testing based on women's preferences","volume":"96","author":"Kuppermann","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.lana.2023.100427_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"A\u00a0controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection","volume":"324","author":"Whitley","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.lana.2023.100427_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archpedi.162.7.665","article-title":"Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates","volume":"162","author":"Caviness","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/tera.1420390102","article-title":"Intrauterine herpes simplex virus infection","volume":"39","author":"Baldwin","year":"1989","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00001432-200406000-00012","article-title":"Neonatal herpes simplex virus infection","volume":"17","author":"Whitley","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.lana.2023.100427_bib54","series-title":"Global burden of disease study 2019 (GBD 2019) reference life table","year":"2021"},{"issue":"4","key":"10.1016\/j.lana.2023.100427_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-Based EQ-5D index scores for chronic conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib57","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/QAI.0b013e3182a5c8d4","article-title":"Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era","volume":"64","author":"Farnham","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib58","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10461-021-03439-x","article-title":"Cost and cost-effectiveness of Incentives for viral suppression in people living with HIV","volume":"26","author":"Dunlap","year":"2022","journal-title":"AIDS Behav"},{"key":"10.1016\/j.lana.2023.100427_bib59","article-title":"Estimation of the lifetime quality-adjusted life Years (QALYs) lost due to syphilis acquired in the United States in 2018","author":"Lee","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lana.2023.100427_bib60","article-title":"Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: a modelling study of overall burden and disparities by age, race\/ethnicity, and other factors","volume":"16","author":"Li","year":"2022","journal-title":"Lancet Regional Health Am"},{"issue":"10","key":"10.1016\/j.lana.2023.100427_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/OLQ.0b013e3182215512","article-title":"The impact of anogenital warts on health-related quality of life: a 6-month prospective study","volume":"38","author":"Drolet","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.lana.2023.100427_bib62","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sextrans-2011-050073","article-title":"The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK","volume":"87","author":"Woodhall","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"50","key":"10.1016\/j.lana.2023.100427_bib63","doi-asserted-by":"crossref","first-page":"8032","DOI":"10.1016\/j.vaccine.2020.10.019","article-title":"Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: estimates from a simplified transmission model","volume":"38","author":"Chesson","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.olq.0000187203.27918.45","article-title":"The public health imperative for a neonatal herpes simplex virus infection surveillance system","volume":"33","author":"Donoval","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"8S","key":"10.1016\/j.lana.2023.100427_bib65","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/OLQ.0000000000001458","article-title":"Assessing the burden of infant deaths due to herpes simplex virus, human immunodeficiency virus, and congenital syphilis: United States, 1995 to 2017","volume":"48","author":"Slutsker","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.lana.2023.100427_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"9","key":"10.1016\/j.lana.2023.100427_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.olq.0000175292.88090.85","article-title":"Neonatal herpes should be a reportable disease","volume":"32","author":"Handsfield","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12955-022-01934-w","article-title":"Health-related quality of life in individuals with genital herpes: a systematic review","volume":"20","author":"Devine","year":"2022","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/sti.2010.045559","article-title":"Projected cost-savings with herpes simplex virus screening in pregnancy: towards a new screening paradigm","volume":"87","author":"Tuite","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.lana.2023.100427_bib70","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ajog.2004.05.034","article-title":"Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy","volume":"191","author":"Baker","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.lana.2023.100427_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2004.09.134","article-title":"The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies","volume":"192","author":"Thung","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lana.2023.100427_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/QAI.0000000000002743","article-title":"What is the burden of heterosexually acquired HIV due to HSV-2? Global and regional model-based estimates of the proportion and number of HIV infections attributable to HSV-2 infection","volume":"88","author":"Silhol","year":"2021","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.lana.2023.100427_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","article-title":"Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management","volume":"13","author":"Bradshaw","year":"2016","journal-title":"Neurotherapeutics"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:53:58Z","timestamp":1757404438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X23000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":74,"alternative-id":["S2667193X23000017"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2023.100427","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime quality-adjusted life years lost due to genital herpes acquired in the United States in 2018: a mathematical modeling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2023.100427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100427"}}